Population geneticist Luigi Luca Cavalli-Sforza has died, The Scientist reports.
The framework, called HEAL, could be used as an early screening test for AAA and as a personal health management tool. In addition, it may be applicable to other complex diseases.
A phylogenetic analysis that included multiple samples per patient suggests overlapping driver mutations make their way into multiple metastases in each patient.
In PNAS this week: DNA vaccine-based approach for Duchenne muscular dystrophy tested in mice, antimicrobial found in bear saliva, and more.
The program was established to support the development and dissemination of functional genomic tools and techniques for genome manipulation in model organisms.
Using genotype and phenotype data from the UK Biobank project, a Stanford investigator uncovered variants linked to low bone mineral density.
The firm aims to commercialize its platform for infectious disease testing in the US by mid to late 2019, and continues to explore additional financing options.
In Cell this week: structural variant profiles for metastatic prostate cancer; approach for visualizing mRNA, lncRNA transcription; and more.
Researchers analyzed a dozen genomes from individuals who lived in Morocco or Iberia during the Neolithic to find a complex population history in North Africa.
The agreement will combine LexaGene's microfluidic instrument and targeted sequencing technology developed at the Stanford University School of Medicine.
US tax agency says 23andMe's genetic health test can be claimed as a medical expense for tax purposes, the Wall Street Journal reports.
The Guardian reports that some UK physicians are calling for increased regulation of direct-to-consumer genetic tests.
Two Democratic lawmakers argue at USA Today that independent science is under attack by the Trump Administration.
In PLOS this week: networks of genes co-expressed in depression, role of minichromosome maintenance genes in lung adenocarcinoma, and more.